Goldman Sachs’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $278K | Buy |
136,774
+6,240
| +5% | +$12.7K | ﹤0.01% | 4558 |
|
|
2025
Q1 | $213K | Sell |
130,534
-159,902
| -55% | -$261K | ﹤0.01% | 4655 |
|
|
2024
Q4 | $531K | Buy |
290,436
+217,246
| +297% | +$398K | ﹤0.01% | 4273 |
|
|
2024
Q3 | $423K | Buy |
73,190
+30,789
| +73% | +$178K | ﹤0.01% | 4195 |
|
|
2024
Q2 | $343K | Buy |
+42,401
| New | +$343K | ﹤0.01% | 4139 |
|
|
2024
Q1 | – | Sell |
-2,920
| Closed | -$214K | – | 4838 |
|
|
2023
Q4 | $214K | Sell |
2,920
-3,013
| -51% | -$221K | ﹤0.01% | 4299 |
|
|
2023
Q3 | $27.7K | Sell |
5,933
-17,481
| -75% | -$81.6K | ﹤0.01% | 4535 |
|
|
2023
Q2 | $125K | Sell |
23,414
-130,019
| -85% | -$697K | ﹤0.01% | 4523 |
|
|
2023
Q1 | $1.51M | Buy |
153,433
+8,725
| +6% | +$85.9K | ﹤0.01% | 3393 |
|
|
2022
Q4 | $2.71M | Sell |
144,708
-44,864
| -24% | -$840K | ﹤0.01% | 3065 |
|
|
2022
Q3 | $3.92M | Buy |
189,572
+65,500
| +53% | +$1.36M | ﹤0.01% | 2830 |
|
|
2022
Q2 | $2.58M | Buy |
124,072
+46,299
| +60% | +$961K | ﹤0.01% | 3245 |
|
|
2022
Q1 | $3.35M | Sell |
77,773
-66,004
| -46% | -$2.84M | ﹤0.01% | 3134 |
|
|
2021
Q4 | $8.61M | Sell |
143,777
-2,606
| -2% | -$156K | ﹤0.01% | 2394 |
|
|
2021
Q3 | $12.6M | Buy |
146,383
+37,924
| +35% | +$3.26M | ﹤0.01% | 2080 |
|
|
2021
Q2 | $12.1M | Buy |
108,459
+87,214
| +411% | +$9.7M | ﹤0.01% | 2113 |
|
|
2021
Q1 | $2.37M | Buy |
21,245
+5,740
| +37% | +$639K | ﹤0.01% | 3235 |
|
|
2020
Q4 | $1.65M | Sell |
15,505
-30,495
| -66% | -$3.24M | ﹤0.01% | 3173 |
|
|
2020
Q3 | $6.4M | Buy |
46,000
+1,583
| +4% | +$220K | ﹤0.01% | 2238 |
|
|
2020
Q2 | $14.4M | Buy |
44,417
+4,315
| +11% | +$1.4M | ﹤0.01% | 1698 |
|
|
2020
Q1 | $3.58M | Buy |
40,102
+24,871
| +163% | +$2.22M | ﹤0.01% | 2447 |
|
|
2019
Q4 | $603K | Buy |
15,231
+6,715
| +79% | +$266K | ﹤0.01% | 3558 |
|
|
2019
Q3 | $209K | Sell |
8,516
-678
| -7% | -$16.6K | ﹤0.01% | 3905 |
|
|
2019
Q2 | $324K | Sell |
9,194
-688
| -7% | -$24.2K | ﹤0.01% | 3696 |
|
|
2019
Q1 | $442K | Sell |
9,882
-7,601
| -43% | -$340K | ﹤0.01% | 3608 |
|
|
2018
Q4 | $839K | Buy |
17,483
+4,115
| +31% | +$197K | ﹤0.01% | 3206 |
|
|
2018
Q3 | $892K | Buy |
13,368
+870
| +7% | +$58.1K | ﹤0.01% | 3236 |
|
|
2018
Q2 | $588K | Buy |
12,498
+991
| +9% | +$46.6K | ﹤0.01% | 3451 |
|
|
2018
Q1 | $650K | Buy |
11,507
+4,086
| +55% | +$231K | ﹤0.01% | 3369 |
|
|
2017
Q4 | $368K | Sell |
7,421
-251
| -3% | -$12.4K | ﹤0.01% | 3575 |
|
|
2017
Q3 | $583K | Sell |
7,672
-7,823
| -50% | -$594K | ﹤0.01% | 3453 |
|
|
2017
Q2 | $1.46M | Buy |
15,495
+8,921
| +136% | +$839K | ﹤0.01% | 2972 |
|
|
2017
Q1 | $522K | Sell |
6,574
-2,747
| -29% | -$218K | ﹤0.01% | 3494 |
|
|
2016
Q4 | $776K | Buy |
9,321
+2,380
| +34% | +$198K | ﹤0.01% | 3216 |
|
|
2016
Q3 | $776K | Buy |
6,941
+2,951
| +74% | +$330K | ﹤0.01% | 3188 |
|
|
2016
Q2 | $442K | Buy |
3,990
+921
| +30% | +$102K | ﹤0.01% | 3391 |
|
|
2016
Q1 | $321K | Buy |
3,069
+2,518
| +457% | +$263K | ﹤0.01% | 3502 |
|
|
2015
Q4 | $44K | Sell |
551
-3,588
| -87% | -$287K | ﹤0.01% | 4214 |
|
|
2015
Q3 | $287K | Sell |
4,139
-8,338
| -67% | -$578K | ﹤0.01% | 3629 |
|
|
2015
Q2 | $1.22M | Buy |
12,477
+533
| +4% | +$52.2K | ﹤0.01% | 2848 |
|
|
2015
Q1 | $1.17M | Sell |
11,944
-10,962
| -48% | -$1.07M | ﹤0.01% | 2814 |
|
|
2014
Q4 | $2.52M | Sell |
22,906
-7,707
| -25% | -$849K | ﹤0.01% | 2372 |
|
|
2014
Q3 | $3.62M | Sell |
30,613
-9,024
| -23% | -$1.07M | ﹤0.01% | 2176 |
|
|
2014
Q2 | $5.14M | Buy |
39,637
+35,426
| +841% | +$4.6M | ﹤0.01% | 1983 |
|
|
2014
Q1 | $673K | Sell |
4,211
-17,443
| -81% | -$2.79M | ﹤0.01% | 3210 |
|
|
2013
Q4 | $3.01M | Buy |
+21,654
| New | +$3.01M | ﹤0.01% | 2348 |
|